These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24382818)

  • 1. Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models.
    Van Hauwermeiren F; Vandenbroucke RE; Grine L; Puimège L; Van Wonterghem E; Zhang H; Libert C
    Int J Cancer; 2014 Aug; 135(3):742-50. PubMed ID: 24382818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
    Van Molle W; Van Roy M; Van Bogaert T; Dejager L; Van Lint P; Vanlaere I; Sekikawa K; Kollias G; Libert C
    Cancer Res; 2007 Aug; 67(15):7301-7. PubMed ID: 17671199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung.
    Zhang M; Qian J; Xing X; Kong FM; Zhao L; Chen M; Lawrence TS
    Clin Cancer Res; 2008 Mar; 14(6):1868-76. PubMed ID: 18347190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium.
    Van Hauwermeiren F; Armaka M; Karagianni N; Kranidioti K; Vandenbroucke RE; Loges S; Van Roy M; Staelens J; Puimège L; Palagani A; Berghe WV; Victoratos P; Carmeliet P; Libert C; Kollias G
    J Clin Invest; 2013 Jun; 123(6):2590-603. PubMed ID: 23676465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
    Miele ME; Bennett CF; Miller BE; Welch DR
    Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
    Van Roy M; Wielockx B; Baker A; Libert C
    Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction.
    Van Hauwermeiren F; Vandenbroucke RE; Grine L; Lodens S; Van Wonterghem E; De Rycke R; De Geest N; Hassan B; Libert C
    Mucosal Immunol; 2015 Jul; 8(4):828-40. PubMed ID: 25425265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
    J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
    Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
    J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P
    Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S; Sauder DN
    Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.
    Rothe J; Lesslauer W; Lötscher H; Lang Y; Koebel P; Köntgen F; Althage A; Zinkernagel R; Steinmetz M; Bluethmann H
    Nature; 1993 Aug; 364(6440):798-802. PubMed ID: 8395024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.
    Deckert-Schlüter M; Bluethmann H; Rang A; Hof H; Schlüter D
    J Immunol; 1998 Apr; 160(7):3427-36. PubMed ID: 9531303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
    Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
    J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.
    Oshima H; Ishikawa T; Yoshida GJ; Naoi K; Maeda Y; Naka K; Ju X; Yamada Y; Minamoto T; Mukaida N; Saya H; Oshima M
    Oncogene; 2014 Jul; 33(29):3820-9. PubMed ID: 23975421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
    Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C
    Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis.
    Huang XW; Yang J; Dragovic AF; Zhang H; Lawrence TS; Zhang M
    Clin Cancer Res; 2006 May; 12(9):2849-55. PubMed ID: 16675580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosterone changes in response to stressors, acute and protracted actions of tumor necrosis factor-alpha, and lipopolysaccharide treatments in mice lacking the tumor necrosis factor-alpha p55 receptor gene.
    Hayley S; Kelly O; Anisman H
    Neuroimmunomodulation; 2004; 11(4):241-6. PubMed ID: 15249730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model.
    Aparicio-Vergara M; Hommelberg PP; Schreurs M; Gruben N; Stienstra R; Shiri-Sverdlov R; Kloosterhuis NJ; de Bruin A; van de Sluis B; Koonen DP; Hofker MH
    Hepatology; 2013 Feb; 57(2):566-76. PubMed ID: 22941955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.